Remove 2025 Remove Clinical Practice Remove Education Remove Provider
article thumbnail

News & Notes: Spring 2025

ABIM

Blueprints provide an outline of what content will appear on an assessment and the relative percentage of the assessment covered by each topic area. The rigorous, formalized blueprint review process includes several steps to gather feedback from physicians, medical specialty societies and medical educators.

article thumbnail

The ICH E6(R3) Guideline: A Major Update to Good Clinical Practice

FDA Law Blog

Livornese As anticipated, the International Council for Harmonization (ICH) published the Good Clinical Practice (GCP) guideline E6(R3) Principles and Annex 1 on January 6, 2025. As stakeholders begin implementing R3, many questions remain regarding its practical application. By Julie Kim & Deborah L.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Rheumatology Board Meeting Summary | Spring 2025

ABIM

Salahuddin Kazi, MD, Chair, Rheumatology Board The Rheumatology Board , which meets twice a year and is responsible for oversight of policy and assessment in the specialty, held its spring meeting on March 11, 2025. Chrostowski, DNP, APRN, ANP-C , Maryah Mansoor, MD , and Philip Seo, MD , whose terms on the Specialty Board end June 30, 2025.

article thumbnail

Growing together: How Sound creates a culture of leadership

Sound Physicians

It is, by design, built into the ways we educate, train, and support our clinical leadership. Fostering leadership potential While not every clinician aspires to be a leader , it ’ s crucial to provide avenues for those who do. Excellent leaders rise to the occasion when opportunities are open and available to them.

article thumbnail

Deprescribing Super Special III: Constance Fung, Emily McDonald, Amy Linsky, and Michelle Odden

GeriPal

Next, we turn to Emily McDonald, the director of the Canadian Medication Appropriateness and Deprescribing Network , to discuss her study on the impact of direct-to-consumer educational brochures on gabapentin deprescribing. Additionally, clinicians participated in monthly educational sessions. Ethical and practical.

article thumbnail

Infectious Disease Board Meeting Summary | Spring 2025

ABIM

Erin Bonura, MD, Chair, ABIM Infectious Disease Board The Infectious Disease Board , which meets twice a year and is responsible for oversight of ABIM policy and assessment in the specialty, held its spring meeting on March 25, 2025. JD , whose terms on the Specialty Board end June 30, 2025.

article thumbnail

Hematology Board Meeting Summary | Spring 2025

ABIM

Gertz, MD, MACP, Chair, ABIM Hematology Board The Hematology Board , which meets twice a year and is responsible for oversight of ABIM policy and assessment in the specialty, held its spring meeting on May 2, 2025. The group discussed policy shifts and potential implications for graduate medical education and health equity.